- Diagnosis and therapy of multiple myeloma
-
Palumbo A, Cerrato C
- KMID: 1776445
- Korean J Intern Med.
- 2013 May;28(3):263-273.
- doi: 10.3904/kjim.2013.28.3.263
Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel agents including thalidomide, lenalidomide, and bortezomib. The first... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathogenesis and Treatment of Intestinal Behcet's Disease
-
Lee CK, Kim HJ
- KMID: 782880
- Korean J Gastroenterol.
- 2007 Jul;50(1):3-8.
Intestinal Behcet's disease (BD) refers to colonic ulcerative lesions documented by objective measures in patients with BD. Although the causes of intestinal BD are unknown, genetic, environmental, and immunological factors... -
- CITED
-
- Close
- SHARE
-
- Close
- Intestinal Diffuse Large B-Cell Lymphoma: An Evaluation of Different Staging Systems
-
Hwang HS, Yoon DH, Suh C, Park CS, Huh J
- KMID: 1796915
- J Korean Med Sci.
- 2014 Jan;29(1):53-60.
- doi: 10.3346/jkms.2014.29.1.53
The gastrointestinal tract is the most common primary extranodal site for diffuse large B-cell lymphoma (DLBCL). However, there is no consensus on the most appropriate staging system for intestinal DLBCL.... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent developments in systemic chemotherapy for hepatocellular carcinoma
-
Han CJ
- KMID: 1073325
- Korean J Hepatol.
- 2008 Mar;14(1):4-11.
- doi: 10.3350/kjhep.2008.14.1.4
Despite recent developments in various chemotherapeutic agents and the performing of numerous clinical trials, chemotherapy still produces unsatisfactory results in hepatocellular carcinoma due to poor clinical benefit compared with untreated... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
-
Lee J, Kim BS, Park Y, Lee JG, Lim BJ, Jeong HJ, Kim YS, Huh KH
- KMID: 2345894
- Yonsei Med J.
- 2015 Nov;56(6):1638-1642.
- doi: 10.3349/ymj.2015.56.6.1638
PURPOSE: Recently, bortezomib has been used to treat antibody-mediated rejection (AMR) refractory to conventional treatment such as plasmapheresis, intravenous immunoglobulin, and rituximab. The authors aimed to describe their experiences when... -
- CITED
-
- Close
- SHARE
-
- Close
- A Patient with Mixed Type Evans Syndrome: Efficacy of Rituximab Treatment
-
Park CY, Chung CH
- KMID: 1713130
- J Korean Med Sci.
- 2006 Dec;21(6):1115-1116.
- doi: 10.3346/jkms.2006.21.6.1115
Mixed type Evans syndrome is a very rare hematologic disease. Although mixed type Evans syndrome may initially respond well to steroids, this disease usually runs a chronic course with intermittent... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Clinical Characteristics and S Gene Mutation of Hepatitis B Virus (HBV) in Patients with Hepatitis B Surface Antigen RIA Negative and HBV DNA Positive
-
Sohn YH, Oh HB, Ko SY, Lim YS, Kwon OJ
- KMID: 1096974
- Korean J Lab Med.
- 2009 Jun;29(3):224-230.
- doi: 10.3343/kjlm.2009.29.3.224
BACKGROUND: We investigated hepatitis B virus (HBV) infection cases, who were HBsAg negative by radioimmunoassay (RIA) and HBV DNA positive for their clinical characteristics, the S gene mutation of hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
